MedTrace Logo

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

NCT07602010 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-05-22

No results posted yet for this study

Summary

This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.

Conditions

  • Bladder Cancer
  • Urothelial Carcinoma (UC)
  • Muscle Invasive Bladder Cancer (MIBC)
  • Non Muscle Invasive Bladder Cancer

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Andreas Habberstad, MD, PhD · Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-22
Primary Completion
2028-04-30
Completion
2028-10-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07602010 on ClinicalTrials.gov